- Home
- CSBR vs RDZN Comparison
CSBR vs RDZN Comparison
Compare CSBR & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- RDZN
- Stock Information
- Founded
- CSBR 1985
- RDZN 2015
- Country
- CSBR United States
- RDZN United States
- Employees
- CSBR N/A
- RDZN N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- RDZN Blank Checks
- Sector
- CSBR Health Care
- RDZN Finance
- Exchange
- CSBR Nasdaq
- RDZN Nasdaq
- Market Cap
- CSBR 90.0M
- RDZN 75.2M
- IPO Year
- CSBR 1986
- RDZN N/A
- Fundamental
- Price
- CSBR $6.53
- RDZN $1.70
- Analyst Decision
- CSBR Strong Buy
- RDZN
- Analyst Count
- CSBR 1
- RDZN 0
- Target Price
- CSBR $12.00
- RDZN N/A
- AVG Volume (30 Days)
- CSBR 10.6K
- RDZN 371.8K
- Earning Date
- CSBR 12-12-2025
- RDZN 11-14-2025
- Dividend Yield
- CSBR N/A
- RDZN N/A
- EPS Growth
- CSBR N/A
- RDZN N/A
- EPS
- CSBR 0.21
- RDZN N/A
- Revenue
- CSBR $56,878,000.00
- RDZN $48,035,296.00
- Revenue This Year
- CSBR $7.31
- RDZN $38.45
- Revenue Next Year
- CSBR $12.01
- RDZN $66.38
- P/E Ratio
- CSBR $30.46
- RDZN N/A
- Revenue Growth
- CSBR 10.11
- RDZN 3.42
- 52 Week Low
- CSBR $4.07
- RDZN $0.68
- 52 Week High
- CSBR $11.99
- RDZN $2.99
- Technical
- Relative Strength Index (RSI)
- CSBR 39.54
- RDZN 66.49
- Support Level
- CSBR $6.67
- RDZN $1.25
- Resistance Level
- CSBR $6.85
- RDZN $1.44
- Average True Range (ATR)
- CSBR 0.17
- RDZN 0.16
- MACD
- CSBR -0.05
- RDZN 0.02
- Stochastic Oscillator
- CSBR 1.79
- RDZN 95.00
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.